A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI
Open Access
- 3 December 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 19 (12), 2300-2303
- https://doi.org/10.1021/bc800211r
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Preclinical Study to Investigate the Development of Nephrogenic Systemic Fibrosis: A Possible Role for Gadolinium-Based Contrast MediaInvestigative Radiology, 2008
- Biochemical safety profiles of gadolinium‐based extracellular contrast agents and nephrogenic systemic fibrosisJournal of Magnetic Resonance Imaging, 2007
- Collagen‐Targeted MRI Contrast Agent for Molecular Imaging of FibrosisAngewandte Chemie, 2007
- Novel Polymerizable Surfactants with pH-Sensitive Amphiphilicity and Cell Membrane Disruption for Efficient siRNA DeliveryBioconjugate Chemistry, 2007
- Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRIProceedings of the National Academy of Sciences of the United States of America, 2007
- Polylysine-Gd-DTPAn and Polylysine-Gd-DOTAn Coupled to Anti-CEA F(ab′)2 Fragments as Potential Immunocontrast AgentsInvestigative Radiology, 1998
- Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoformNature Biotechnology, 1997
- The Demonstration of Human Tumors on Nude Mice Using Gadolinium-Labelled Monoclonal Antibodies for Magnetic Resonance ImagingInvestigative Radiology, 1993
- Regulation of Extravascular Coagulation by Microvascular PermeabilityScience, 1985
- Fibronectin in human solid tumorsInternational Journal of Cancer, 1981